http://neuroderm.com/

http://neuroderm.com/neuroderm-annou...nsons-disease/

gotta wonder if insurance companies are going to pay for the incredibly expensive carbidopa/l-dopa that they use, if it's anything close to what is used in the duodopa pump, which has not yet been approved in the U.S., the cost could be well over $25,000/year. plus i assume you'll have the same problems with protein interference with l-dopa passing thru the BBB that you get with oral l-dopa

i may be wrong but sure seems like a better agonist in a controlled release form with fewer side affects would be a better solution than a pump, and the current options mirapex-xl, requip-xl and the neupro patch are too expensive imho. i'm glad this will be an option, just thinking out loud.